BLTE · Belite Bio, Inc
$162.80
-3.48 (-2.09%)
At close · Aug 14
Market Cap
$6.53B
Shares
40.09M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BLTE
26 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | — | 207,862 | $33,141,517 | 0.30% | Long | 2026-03-31 | |
| ALGER SMALL CAP FOCUS FUND | — | 61,867 | $9,846,752 | 1.25% | Long | 2026-04-30 | |
| Eventide Healthcare & Life Sciences Fund | — | 29,026 | $4,627,905 | 0.29% | Long | 2026-03-31 | |
| Morgan Stanley Discovery Portfolio | — | 15,913 | $2,537,169 | 0.23% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 12,700 | $2,024,888 | 0.31% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF | — | 12,456 | $1,985,985 | 0.01% | Long | 2026-03-31 | |
| Discovery Portfolio | — | 10,859 | $1,731,359 | 0.23% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 6,727 | $969,899 | 0.00% | Long | 2026-05-31 | |
| Fidelity ZERO International Index Fund | — | 5,001 | $795,959 | 0.01% | Long | 2026-04-30 | |
| Health Sciences Trust | — | 4,800 | $765,312 | 0.34% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 3,734 | $538,368 | 0.00% | Long | 2026-05-31 | |
| ActivePassive International Equity ETF | — | 3,713 | $535,340 | 0.05% | Long | 2026-05-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 3,300 | $526,152 | 0.33% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) China ETF | — | 3,192 | $508,932 | 0.11% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 3,100 | $446,958 | 0.01% | Long | 2026-05-31 | |
| Discovery Portfolio | — | 2,474 | $394,455 | 0.23% | Long | 2026-03-31 | |
| Global Endurance Portfolio | — | 2,053 | $327,330 | 2.11% | Long | 2026-03-31 | |
| Virtus Biotech Clinical Trials Etf | — | 1,952 | $310,680 | 0.83% | Long | 2026-04-30 | |
| Fidelity Flex International Index Fund | — | 1,889 | $300,653 | 0.01% | Long | 2026-04-30 | |
| ULTRACHINA PROFUND | — | 956 | $152,157 | 0.68% | Long | 2026-04-30 | |
| ALGER HEALTH SCIENCES FUND | — | 786 | $125,100 | 0.21% | Long | 2026-04-30 | |
| Parametric Tax-Managed Emerging Markets Fund | — | 781 | $124,523 | 0.02% | Long | 2026-03-31 | |
| ALGER SMALL CAP GROWTH FUND | — | 649 | $103,295 | 0.05% | Long | 2026-04-30 | |
| Alger Small Cap Growth Portfolio | — | 489 | $77,966 | 0.06% | Long | 2026-03-31 | |
| ALGER SMALL CAP GROWTH INSTITUTIONAL FUND | — | 248 | $39,472 | 0.06% | Long | 2026-04-30 | |
| T. Rowe Price Innovation Leaders ETF | — | 117 | $18,654 | 0.12% | Long | 2026-03-31 |
Showing 1–26 of 26 positions
Key facts
CIK
1889109
CUSIP
07782B104
13F (30d)
82 filings
81 filers
Visit website
Investor relations